These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24482044)

  • 1. MicroRNA‑34a/c function as tumor suppressors in Hep‑2 laryngeal carcinoma cells and may reduce GALNT7 expression.
    Li W; Ma H; Sun J
    Mol Med Rep; 2014 Apr; 9(4):1293-8. PubMed ID: 24482044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-154 inhibits the growth of laryngeal squamous cell carcinoma by targeting GALNT7.
    Niu JT; Zhang LJ; Huang YW; Li C; Jiang N; Niu YJ
    Biochem Cell Biol; 2018 Dec; 96(6):752-760. PubMed ID: 29874469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
    Ye J; Li L; Feng P; Wan J; Li J
    Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-214 inhibits invasion and migration via downregulating GALNT7 in esophageal squamous cell cancer.
    Lu Q; Xu L; Li C; Yuan Y; Huang S; Chen H
    Tumour Biol; 2016 Nov; 37(11):14605-14614. PubMed ID: 27619677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC).
    Yungang W; Xiaoyu L; Pang T; Wenming L; Pan X
    Biomed Pharmacother; 2014 Mar; 68(2):149-54. PubMed ID: 24055400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.
    Zhang T; Liu M; Wang C; Lin C; Sun Y; Jin D
    Anticancer Res; 2011 Nov; 31(11):3859-63. PubMed ID: 22110210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
    Jili S; Eryong L; Lijuan L; Chao Z
    Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-1297 mediates PTEN expression and contributes to cell progression in LSCC.
    Li X; Wang HL; Peng X; Zhou HF; Wang X
    Biochem Biophys Res Commun; 2012 Oct; 427(2):254-60. PubMed ID: 22995297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met.
    Cai KM; Bao XL; Kong XH; Jinag W; Mao MR; Chu JS; Huang YJ; Zhao XJ
    Int J Mol Med; 2010 Apr; 25(4):565-71. PubMed ID: 20198305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-34c-5p is related to recurrence in laryngeal squamous cell carcinoma.
    Re M; Çeka A; Rubini C; Ferrante L; Zizzi A; Gioacchini FM; Tulli M; Spazzafumo L; Sellari-Franceschini S; Procopio AD; Olivieri F
    Laryngoscope; 2015 Sep; 125(9):E306-12. PubMed ID: 26153151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down-regulation of the S100A8 protein.
    Guo Y; Fu W; Chen H; Shang C; Zhong M
    Oncol Rep; 2012 Apr; 27(4):1097-103. PubMed ID: 22139384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression Levels and Clinical Significance of miR-21-5p, miR-let-7a, and miR-34c-5p in Laryngeal Squamous Cell Carcinoma.
    Re M; Magliulo G; Gioacchini FM; Bajraktari A; Bertini A; Çeka A; Rubini C; Ferrante L; Procopio AD; Olivieri F
    Biomed Res Int; 2017; 2017():3921258. PubMed ID: 29082244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-375 exhibits a more effective tumor-suppressor function in laryngeal squamous carcinoma cells by regulating KLF4 expression compared with simple co-transfection of miR-375 and miR-206.
    Guo Y; An R; Zhao R; Sun Y; Liu M; Tian L
    Oncol Rep; 2016 Aug; 36(2):952-60. PubMed ID: 27279635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8.
    Li M; Tian L; Ren H; Chen X; Wang Y; Ge J; Wu S; Sun Y; Liu M; Xiao H
    J Transl Med; 2015 Aug; 13():271. PubMed ID: 26286725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-205 promotes proliferation and invasion of laryngeal squamous cell carcinoma by suppressing CDK2AP1 expression.
    Zhong G; Xiong X
    Biol Res; 2015 Oct; 48():60. PubMed ID: 26515287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-16 targets zyxin and promotes cell motility in human laryngeal carcinoma cell line HEp-2.
    Wu H; Liu T; Wang R; Tian S; Liu M; Li X; Tang H
    IUBMB Life; 2011 Feb; 63(2):101-8. PubMed ID: 21360639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.
    Shen Z; Zhou C; Li J; Ye D; Li Q; Wang J; Cui X; Chen X; Bao T; Duan S
    Gene; 2016 Nov; 593(2):272-6. PubMed ID: 27450916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of miR -155 promotes proliferation and invasion of human laryngeal squamous cell carcinoma via targeting SOCS1 and STAT3.
    Zhao XD; Zhang W; Liang HJ; Ji WY
    PLoS One; 2013; 8(2):e56395. PubMed ID: 23437123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
    Liu M; Wu H; Liu T; Li Y; Wang F; Wan H; Li X; Tang H
    Cell Res; 2009 Jul; 19(7):828-37. PubMed ID: 19546886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2.
    Yu W; Zhang G; Lu B; Li J; Wu Z; Ma H; Wang H; Lian R
    Gene; 2016 Feb; 577(2):193-201. PubMed ID: 26656176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.